๐๏ธ Ovarian Cancer โ Types, Causes, Symptoms, Diagnosis & Treatment
A complete guide to ovarian cancer: understanding the causes, symptoms, types, diagnosis, and effective treatment options for this serious gynecological cancer
๐ Table of Contents
๐ค What is Ovarian Cancer?
Ovarian cancer is a type of cancer that begins in the ovaries or fallopian tubes. It occurs when abnormal cells in the ovaries grow uncontrollably and form tumors. Ovarian cancer is the seventh most common cancer among women worldwide and primarily affects postmenopausal women over 50.
Key facts about ovarian cancer:
- 7th most common cancer in women: A major gynecological cancer
- Often diagnosed late: More than 70% of cases are Stage III or IV
- Most common type: Epithelial ovarian cancer (90% of cases)
- Hereditary link: About 10% of cases are linked to BRCA mutations
- No effective screening: No recommended screening test for average-risk women
๐ Types of Ovarian Cancer
Ovarian cancer is classified based on the type of cells involved. Epithelial ovarian cancer is by far the most common type, accounting for approximately 90% of all diagnoses.
Serous Carcinoma
- Most common โ 80% of advanced cases
- Subdivided into high-grade and low-grade
- High-grade is the most aggressive type
- Often linked to BRCA mutations
Mucinous Carcinoma
- 7-14% of cases
- Very good prognosis if caught early
- Often confused with colon cancer spread
- May be associated with smoking
Endometrioid Carcinoma
- ~10% of cases
- Typically low-grade
- Often diagnosed at early stage
- Associated with endometriosis
Clear-Cell Carcinoma
- ~5% of cases
- Good prognosis if diagnosed early
- Associated with endometriosis
- Less responsive to chemotherapy
๐ Stages of Ovarian Cancer
Ovarian cancer is staged using the FIGO system (International Federation of Gynecology and Obstetrics), which classifies cancer from Stage I to IV.
Stage I
Cancer is confined to the ovaries. 5-year survival: ~87%
Stage II
Cancer has spread to nearby pelvic organs. 5-year survival: ~76%
Stage III
Cancer has spread to the abdomen. 5-year survival: ~42%
Stage IV
Cancer has spread to distant organs. 5-year survival: ~28%
โ ๏ธ Who Is at Higher Risk?
Most women who develop ovarian cancer are not considered high risk. However, several factors can increase a woman's likelihood of developing the disease.
Non-Modifiable Risk Factors
Age
Most common after age 50
Family History
3.6x higher risk with first-degree relative
BRCA1/BRCA2 Mutations
28-44% lifetime risk
Endometriosis
Modest increased risk
Never Given Birth
Higher risk than women who have
Lynch Syndrome
Inherited cancer syndrome
Modifiable Risk Factors
Hormone Therapy
Long-term estrogen use increases risk
Obesity
Modest increased risk
Smoking
Increases risk of mucinous type
Protective Factors
Oral Contraceptives
Significantly reduces risk
Tubal Ligation
Reduces risk by ~30%
Multiparity
Multiple pregnancies reduce risk
Breastfeeding
Associated with decreased risk
๐ Causes & Risk Factors
The exact cause of ovarian cancer is unknown, but several factors can increase the risk. The most significant is genetic mutations.
BRCA1/BRCA2
#1 genetic risk factor
Age
Risk increases with age
Family History
First-degree relative with ovarian cancer
Endometriosis
Chronic inflammation increases risk
Hormone Therapy
Long-term estrogen use
Obesity
Modest increased risk
Smoking
Increases risk of mucinous type
Lynch Syndrome
Inherited cancer syndrome
๐จ Symptoms of Ovarian Cancer
Ovarian cancer symptoms are often vague and can be mistaken for other conditions. Early-stage disease often has no symptoms at all. Common symptoms include:
Bloating
Persistent abdominal bloating or swelling
Pelvic Pain
Pain or pressure in the pelvic area
Feeling Full Quickly
Difficulty eating or feeling full fast
Urinary Symptoms
Frequent or urgent urination
Weight Loss
Unexplained weight loss
Fatigue
Persistent tiredness
- Persistent bloating lasting more than 2 weeks
- Pelvic or abdominal pain that doesn't go away
- Difficulty eating or feeling full quickly
- Urinary symptoms โ frequency or urgency
- Unexplained weight loss
๐ Early Warning Signs of Ovarian Cancer
Recognizing the early warning signs of ovarian cancer can lead to earlier diagnosis and better outcomes. Unfortunately, early ovarian cancer is often asymptomatic.
๐ Early Signs to Watch For:
- Persistent bloating โ especially if new and lasting more than 2 weeks
- Pelvic or abdominal pain โ persistent or worsening
- Feeling full quickly โ difficulty eating
- Urinary urgency or frequency โ new onset
- Unexplained weight loss
- Fatigue โ persistent and unexplained
๐ฉบ Diagnosis: What Doctors Actually Look For
Diagnosing ovarian cancer involves several tests and procedures. Here's what doctors actually look for during the diagnostic process:
Initial Evaluation
Medical History
Review symptoms and risk factors
Pelvic Exam
Doctor feels for masses or abnormalities
Transvaginal Ultrasound
Primary imaging tool for ovaries
CA125 Blood Test
Tumor marker โ elevated in many cases
RMI Score
Risk of Malignancy Index โ guides referral
CT Scan
Detailed images to assess spread
Advanced Diagnostic Tools
Biopsy
Tissue sample to confirm cancer
Genetic Testing
BRCA1/2 and other gene mutations
HRD Testing
Homologous Recombination Deficiency
๐ Prognosis & Outlook
Survival rates for ovarian cancer vary significantly by stage at diagnosis. Understanding your prognosis can help you make informed treatment decisions.
5-Year Survival by Stage
Stage I
5-year survival: 87%
Stage II
5-year survival: 76%
Stage III
5-year survival: 42%
Stage IV
5-year survival: 28%
Conditional Survival: A Dynamic Perspective
Traditional survival statistics are static, but prognosis actually improves with time survived. A study of 808 patients with advanced ovarian cancer found:
- The 1-year conditional survival increased from 87% at 6 months to 95% at 5 years after surgery.
- The 5-year conditional survival rose from 49% to 66% over the same period.
- Approximately 11% of patients achieved survival beyond 10 years.
Factors That Improve Survival
- Platinum-taxane chemotherapy: 43% reduction in mortality risk
- BRCA1/2 testing: 34% reduction in mortality risk
- No residual disease after surgery: 52% reduction in mortality risk
- Treatment at high-volume centers: Improved outcomes
๐ Treatment Options
Treatment for ovarian cancer depends on the stage, type, and genetic makeup of the cancer. The main treatment options are:
Surgery
Primary treatment โ debulking surgery to remove as much tumor as possible. May include hysterectomy, oophorectomy, and lymph node removal.
Chemotherapy
Platinum-taxane chemotherapy is the standard. Usually given after surgery (adjuvant) or before (neoadjuvant).
Targeted Therapy
PARP inhibitors (olaparib, niraparib) for BRCA-mutated cancers. Bevacizumab (Avastin) for advanced disease.
Immunotherapy
Helps the immune system recognize and attack cancer cells. Used for recurrent or advanced ovarian cancer.
Radiation Therapy
Rarely used for ovarian cancer, but may be used for palliative care or recurrent disease.
Hormone Therapy
Used for some types of ovarian cancer, especially low-grade serous or endometrioid types.
โ Common Questions About Ovarian Cancer
Early-stage disease often has no symptoms. When symptoms do appear, they may include abdominal or pelvic pain, bloating, feeling full quickly, frequent urination, and fatigue. These symptoms are common and usually caused by non-cancerous conditions, but persistent symptoms lasting more than two weeks warrant medical evaluation.
There is no guaranteed prevention, but risk-reducing strategies exist. Oral contraceptives reduce risk, and tubal ligation lowers risk by about 30%. For women with BRCA mutations, risk-reducing salpingo-oophorectomy (surgical removal of tubes and ovaries) is the most effective prevention.
About 10% of ovarian cancers are hereditary. The most common genetic causes are BRCA1 and BRCA2 mutations. Women with these mutations have a 28-44% lifetime risk. Genetic counseling is recommended for women with a strong family history.
Staging ranges from Stage I (confined to ovaries) to Stage IV (spread to distant organs). Staging is determined surgically and guides treatment decisions.
Primary treatment is surgery (debulking to remove as much tumor as possible), followed by platinum-taxane chemotherapy. Targeted therapies like bevacizumab and PARP inhibitors (olaparib, niraparib) are used for maintenance or recurrent disease, especially in BRCA-mutated cancers.
Yes. Multiple pregnancies (multiparity) are associated with a decreased risk of ovarian cancer. Breastfeeding also appears protective.
5-year survival rates are 87% for Stage I, 76% for Stage II, 42% for Stage III, and 28% for Stage IV. Conditional survival improves with time survived.
There is currently no recommended screening test for ovarian cancer in average-risk women. The UKCTOCS trial showed only a modest mortality reduction with CA125 monitoring and ultrasound.
๐ก๏ธ Prevention Strategies
While there is no guaranteed way to prevent ovarian cancer, several strategies can help lower your risk:
Oral Contraceptives
Significantly reduces risk
Tubal Ligation
Reduces risk by ~30%
Multiparity
Multiple pregnancies reduce risk
Breastfeeding
Associated with decreased risk
Maintain Healthy Weight
Obesity increases risk
Quit Smoking
Increases risk of mucinous type
Genetic Testing
If you have family history
Regular Checkups
See a doctor for persistent symptoms
โ Do's and Don'ts
โ Do's
- See a doctor for persistent bloating
- Know your family history
- Consider genetic testing if high risk
- Maintain a healthy weight
- Exercise regularly
- Consider oral contraceptives for risk reduction
- See a gynecologic oncologist if diagnosed
โ Don'ts
- Don't ignore persistent bloating
- Don't ignore pelvic pain
- Don't smoke
- Avoid excessive hormone therapy
- Don't delay medical evaluation
- Don't skip regular checkups
- Don't assume symptoms are "just gas"
๐จโโ๏ธ Which Doctor to See
๐ Sources & Medical References
The information in this guide is based on the following medical sources and references:
- National Cancer Institute. "Ovarian, Fallopian Tube, and Primary Peritoneal Cancers Prevention (PDQยฎ)." NCBI Bookshelf, 2025.
- Norwegian Directorate of Health. "Diagnostikk og utredning" (Diagnostics and Investigation), Gynecological Cancer Guidelines, 2025.
- Farzaliyeva A, et al. "Shifting Survival Horizons in Advanced Ovarian Cancer: A Conditional Survival Perspective." Current Oncology, 2025.
- Centers for Disease Control and Prevention. "Ovarian Cancer Risk Factors." CDC.gov, 2025.
- National Cancer Institute. "Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms." Prevention.cancer.gov, 2026.
- American Cancer Society. "Ovarian Cancer Survival Rates." Cancer.org, 2025.
- National Cancer Information Center (Korea). "๋์์ ๋ฐ์ ์์ธ" (Causes of Ovarian Cancer). Cancer.go.kr.
- Mayo Clinic. "Ovarian Cancer: Diagnosis & Treatment." MayoClinic.org, 2025.
- "Quality Matters: Linking Patterns of Care to Ovarian Cancer Survival in a National Gynae-Oncology Registry." JCO Oncology Practice, 2026.
- ESMO. "Ovarian Cancer Guide for Patients." ESMO.org.
- ScienceDirect. "Epithelial ovarian cancer: The most common subtype." 2025.
- Taylor & Francis. "Surgery for Ovarian and Tubal Cancer." Atlas of Procedures in Gynecologic Oncology, 2026.
- ESMO. "Cรกncer de Ovario: Guรญa para Pacientes" (Spanish Edition). ESMO.org.
๐ฏ Conclusion
Ovarian cancer is a serious cancer that is often diagnosed at an advanced stage. Understanding the risk factors โ especially BRCA mutations and family history โ and recognizing the early warning signs can lead to earlier diagnosis and better outcomes. If you have persistent bloating, pelvic pain, or other symptoms, see a doctor promptly.
๐ช Remember: Early detection saves lives. If you have risk factors for ovarian cancer, talk to your doctor about genetic counseling and risk-reducing strategies. And if you experience persistent symptoms, don't wait โ see your doctor.
โ ๏ธ Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Always consult a healthcare provider for proper diagnosis and treatment.